{"id":40454,"date":"2003-01-01T12:00:00","date_gmt":"2003-01-01T11:00:00","guid":{"rendered":"https:\/\/der-arzneimittelbrief.com\/artikel\/2003\/neue-arzneimittel"},"modified":"2003-01-01T12:00:00","modified_gmt":"2003-01-01T11:00:00","slug":"neue-arzneimittel","status":"publish","type":"post","link":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/neue-arzneimittel\/","title":{"rendered":"Neue Arzneimittel"},"content":{"rendered":"<p>Im Oktober ist der Arzneiverordnungs-Report 2002 erschienen (1). Er gibt wie immer einen in den Medien viel beachteten \u00dcberblick \u00fcber das Verordnungsverhalten der deutschen \u00c4rzte im Vorjahr. 3,5 Millionen kassen\u00e4rztliche Rezepte des Jahres 2001 wurden ausgewertet. Der Anteil der umstrittenen Arzneimittel an den Verordnungen ist gesunken. Das Einsparpotential hier betr\u00e4gt aber noch 1,2 Milliarden EUR. [&hellip;]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Im Oktober ist der Arzneiverordnungs-Report 2002 erschienen (1). Er gibt wie immer einen in den Medien viel beachteten \u00dcberblick \u00fcber das Verordnungsverhalten der deutschen \u00c4rzte im Vorjahr. 3,5 Millionen kassen\u00e4rztliche Rezepte des Jahres 2001 wurden ausgewertet. Der Anteil der umstrittenen Arzneimittel an den Verordnungen ist gesunken. Das Einsparpotential hier betr\u00e4gt aber noch 1,2 Milliarden EUR. [&hellip;]<\/p>\n","protected":false},"author":6,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_editorskit_title_hidden":false,"_editorskit_reading_time":0,"_editorskit_is_block_options_detached":false,"_editorskit_block_options_position":"{}","footnotes":""},"categories":[1],"tags":[3937,3938,3967,2760,1749,98,4321,4331,2537,438,4479,4537,4540,48,49,4628,4646,4669,2500,4755,4792,2398,374,1755,4968,1679,1295,5110,5111,469,2609,451,389,5597,1597,5610,412,5662,5676,99,2406,778,5767,3308,751,5924,821,852,3056,6167,6244,697,759,760,1913,1912,6338,1965,1964,194,6434,6503,6504,1039,6637,823,6724,6815,1491,6864,795,2544,170,2236,1790,55],"class_list":["post-40454","post","type-post","status-publish","format-standard","hentry","category-allgemein","tag-agalsidase-alfa","tag-agalsidase-beta","tag-alemtuxumab","tag-almotriptan","tag-aromatasehemmer","tag-arzneimittel","tag-botulinumtoxin-typ-b","tag-brinzolamid","tag-capecitabin","tag-celecoxib","tag-choriongonadotropin-alfa","tag-clostridium-botulinum-toxin-typ-b","tag-co-artemether","tag-cox-2-hemmer","tag-coxibe","tag-darbepoetin-alfa","tag-deferipron","tag-desloratadin","tag-dexibuprofen","tag-drospirenon-oestrogen","tag-eiseniii-hydroxid-dextrankomplex","tag-esomeprazol","tag-etanercept","tag-exemestan","tag-ferucarbotran","tag-galantamin","tag-gatifloxacin","tag-glatirameracetat","tag-glatiramerazetat","tag-her2","tag-human-epidermal-growth-factor-receptor-2","tag-imatinib","tag-insulin-glargin","tag-lercanidipin","tag-levetiracetam","tag-levocetirizin","tag-linezolid","tag-lopinavir","tag-lutropin-alfa","tag-medikamente","tag-meningokokken","tag-meningokokken-impfung","tag-meningokokken-meningitis","tag-meningokokkenimpfung","tag-meningokokkenmeningitis","tag-nateglinid","tag-no","tag-orale-antidiabetika","tag-oxcarbazepin","tag-peginterferon-alfa-2b","tag-pioglitazon","tag-pneumokokken","tag-pneumokokken-impfstoff","tag-pneumokokken-impfung","tag-pneumokokkenimpfstoff","tag-pneumokokkenimpfung","tag-proetin-c","tag-protonenpumpen-hemmer","tag-protonenpumpenhemmer","tag-quetiapin","tag-rasburicase","tag-risedronat","tag-risedronsaeure","tag-rosiglitazon","tag-sirolimus","tag-stickoxid","tag-stickstoffmonoxid","tag-telithromycin","tag-tenecteplase","tag-thyrotropin-alfa","tag-trastuzumab","tag-tyrosinkinase-hemmer","tag-tyrosinkinase-inhibitoren","tag-zoledronat","tag-zoledronsaeure","tag-zyklooxygenase-2-hemmer"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Neue Arzneimittel - Der Arzneimittelbrief<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/neue-arzneimittel\/\" \/>\n<meta property=\"og:locale\" content=\"de_DE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Neue Arzneimittel - Der Arzneimittelbrief\" \/>\n<meta property=\"og:description\" content=\"Im Oktober ist der Arzneiverordnungs-Report 2002 erschienen (1). Er gibt wie immer einen in den Medien viel beachteten \u00dcberblick \u00fcber das Verordnungsverhalten der deutschen \u00c4rzte im Vorjahr. 3,5 Millionen kassen\u00e4rztliche Rezepte des Jahres 2001 wurden ausgewertet. Der Anteil der umstrittenen Arzneimittel an den Verordnungen ist gesunken. Das Einsparpotential hier betr\u00e4gt aber noch 1,2 Milliarden EUR. [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/neue-arzneimittel\/\" \/>\n<meta property=\"og:site_name\" content=\"Der Arzneimittelbrief\" \/>\n<meta property=\"article:publisher\" content=\"http:\/\/www.facebook.com\/derarzneimittelbrief.de\" \/>\n<meta property=\"article:published_time\" content=\"2003-01-01T11:00:00+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2003\/01\/Abbildung-2003-1-2.gif\" \/>\n<meta name=\"author\" content=\"Dennis Hoppe\" \/>\n<meta name=\"twitter:label1\" content=\"Verfasst von\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dennis Hoppe\" \/>\n\t<meta name=\"twitter:label2\" content=\"Gesch\u00e4tzte Lesezeit\" \/>\n\t<meta name=\"twitter:data2\" content=\"8\u00a0Minuten\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/neue-arzneimittel\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/neue-arzneimittel\\\/\"},\"author\":{\"name\":\"Dennis Hoppe\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#\\\/schema\\\/person\\\/a04aadd6db7c06c7464bdbbb5396ed16\"},\"headline\":\"Neue Arzneimittel\",\"datePublished\":\"2003-01-01T11:00:00+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/neue-arzneimittel\\\/\"},\"wordCount\":1597,\"image\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/neue-arzneimittel\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/wp-content\\\/uploads\\\/2003\\\/01\\\/Abbildung-2003-1-2.gif\",\"keywords\":[\"Agalsidase alfa\",\"Agalsidase beta\",\"Alemtuxumab\",\"Almotriptan\",\"Aromatasehemmer\",\"Arzneimittel\",\"Botulinumtoxin Typ B\",\"Brinzolamid\",\"Capecitabin\",\"Celecoxib\",\"Choriongonadotropin alfa\",\"Clostridium-botulinum-Toxin Typ B\",\"Co-Artemether\",\"COX-2-Hemmer\",\"Coxibe\",\"Darbepoetin alfa\",\"Deferipron\",\"Desloratadin\",\"Dexibuprofen\",\"Drospirenon\\\/\u00d6strogen\",\"Eisen(III)-hydroxid-Dextrankomplex\",\"Esomeprazol\",\"Etanercept\",\"Exemestan\",\"Ferucarbotran\",\"Galantamin\",\"Gatifloxacin\",\"Glatirameracetat\",\"Glatiramerazetat\",\"HER2\",\"Human epidermal growth factor receptor 2\",\"Imatinib\",\"Insulin glargin\",\"Lercanidipin\",\"Levetiracetam\",\"Levocetirizin\",\"Linezolid\",\"Lopinavir\",\"Lutropin alfa\",\"Medikamente\",\"Meningokokken\",\"Meningokokken-Impfung\",\"Meningokokken-Meningitis\",\"Meningokokkenimpfung\",\"Meningokokkenmeningitis\",\"Nateglinid\",\"NO\",\"Orale Antidiabetika\",\"Oxcarbazepin\",\"Peginterferon alfa-2b\",\"Pioglitazon\",\"Pneumokokken\",\"Pneumokokken-Impfstoff\",\"Pneumokokken-Impfung\",\"Pneumokokkenimpfstoff\",\"Pneumokokkenimpfung\",\"Proetin C\",\"Protonenpumpen-Hemmer\",\"Protonenpumpenhemmer\",\"Quetiapin\",\"Rasburicase\",\"Risedronat\",\"Risedrons\u00e4ure\",\"Rosiglitazon\",\"Sirolimus\",\"Stickoxid\",\"Stickstoffmonoxid\",\"Telithromycin\",\"Tenecteplase\",\"Thyrotropin alfa\",\"Trastuzumab\",\"Tyrosinkinase-Hemmer\",\"Tyrosinkinase-Inhibitoren\",\"Zoledronat\",\"Zoledrons\u00e4ure\",\"Zyklooxygenase-2-Hemmer\"],\"inLanguage\":\"de\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/neue-arzneimittel\\\/\",\"url\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/neue-arzneimittel\\\/\",\"name\":\"Neue Arzneimittel - Der Arzneimittelbrief\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/neue-arzneimittel\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/neue-arzneimittel\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/wp-content\\\/uploads\\\/2003\\\/01\\\/Abbildung-2003-1-2.gif\",\"datePublished\":\"2003-01-01T11:00:00+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#\\\/schema\\\/person\\\/a04aadd6db7c06c7464bdbbb5396ed16\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/neue-arzneimittel\\\/#breadcrumb\"},\"inLanguage\":\"de\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/neue-arzneimittel\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/neue-arzneimittel\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/wp-content\\\/uploads\\\/2003\\\/01\\\/Abbildung-2003-1-2.gif\",\"contentUrl\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/wp-content\\\/uploads\\\/2003\\\/01\\\/Abbildung-2003-1-2.gif\",\"width\":500,\"height\":529},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/neue-arzneimittel\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Start\",\"item\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Neue Arzneimittel\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#website\",\"url\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/\",\"name\":\"Der Arzneimittelbrief\",\"description\":\"Unabh\u00e4ngige Arzneimittelinformationen\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"de\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.der-arzneimittelbrief.de\\\/nachrichten\\\/#\\\/schema\\\/person\\\/a04aadd6db7c06c7464bdbbb5396ed16\",\"name\":\"Dennis Hoppe\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"de\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bfb16656c0e1636d4f543ef457ada76f291324632a293160dd5c869cc3b071d7?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bfb16656c0e1636d4f543ef457ada76f291324632a293160dd5c869cc3b071d7?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/bfb16656c0e1636d4f543ef457ada76f291324632a293160dd5c869cc3b071d7?s=96&d=mm&r=g\",\"caption\":\"Dennis Hoppe\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Neue Arzneimittel - Der Arzneimittelbrief","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/neue-arzneimittel\/","og_locale":"de_DE","og_type":"article","og_title":"Neue Arzneimittel - Der Arzneimittelbrief","og_description":"Im Oktober ist der Arzneiverordnungs-Report 2002 erschienen (1). Er gibt wie immer einen in den Medien viel beachteten \u00dcberblick \u00fcber das Verordnungsverhalten der deutschen \u00c4rzte im Vorjahr. 3,5 Millionen kassen\u00e4rztliche Rezepte des Jahres 2001 wurden ausgewertet. Der Anteil der umstrittenen Arzneimittel an den Verordnungen ist gesunken. Das Einsparpotential hier betr\u00e4gt aber noch 1,2 Milliarden EUR. [&hellip;]","og_url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/neue-arzneimittel\/","og_site_name":"Der Arzneimittelbrief","article_publisher":"http:\/\/www.facebook.com\/derarzneimittelbrief.de","article_published_time":"2003-01-01T11:00:00+00:00","og_image":[{"url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2003\/01\/Abbildung-2003-1-2.gif","type":"","width":"","height":""}],"author":"Dennis Hoppe","twitter_misc":{"Verfasst von":"Dennis Hoppe","Gesch\u00e4tzte Lesezeit":"8\u00a0Minuten"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/neue-arzneimittel\/#article","isPartOf":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/neue-arzneimittel\/"},"author":{"name":"Dennis Hoppe","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#\/schema\/person\/a04aadd6db7c06c7464bdbbb5396ed16"},"headline":"Neue Arzneimittel","datePublished":"2003-01-01T11:00:00+00:00","mainEntityOfPage":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/neue-arzneimittel\/"},"wordCount":1597,"image":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/neue-arzneimittel\/#primaryimage"},"thumbnailUrl":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2003\/01\/Abbildung-2003-1-2.gif","keywords":["Agalsidase alfa","Agalsidase beta","Alemtuxumab","Almotriptan","Aromatasehemmer","Arzneimittel","Botulinumtoxin Typ B","Brinzolamid","Capecitabin","Celecoxib","Choriongonadotropin alfa","Clostridium-botulinum-Toxin Typ B","Co-Artemether","COX-2-Hemmer","Coxibe","Darbepoetin alfa","Deferipron","Desloratadin","Dexibuprofen","Drospirenon\/\u00d6strogen","Eisen(III)-hydroxid-Dextrankomplex","Esomeprazol","Etanercept","Exemestan","Ferucarbotran","Galantamin","Gatifloxacin","Glatirameracetat","Glatiramerazetat","HER2","Human epidermal growth factor receptor 2","Imatinib","Insulin glargin","Lercanidipin","Levetiracetam","Levocetirizin","Linezolid","Lopinavir","Lutropin alfa","Medikamente","Meningokokken","Meningokokken-Impfung","Meningokokken-Meningitis","Meningokokkenimpfung","Meningokokkenmeningitis","Nateglinid","NO","Orale Antidiabetika","Oxcarbazepin","Peginterferon alfa-2b","Pioglitazon","Pneumokokken","Pneumokokken-Impfstoff","Pneumokokken-Impfung","Pneumokokkenimpfstoff","Pneumokokkenimpfung","Proetin C","Protonenpumpen-Hemmer","Protonenpumpenhemmer","Quetiapin","Rasburicase","Risedronat","Risedrons\u00e4ure","Rosiglitazon","Sirolimus","Stickoxid","Stickstoffmonoxid","Telithromycin","Tenecteplase","Thyrotropin alfa","Trastuzumab","Tyrosinkinase-Hemmer","Tyrosinkinase-Inhibitoren","Zoledronat","Zoledrons\u00e4ure","Zyklooxygenase-2-Hemmer"],"inLanguage":"de"},{"@type":"WebPage","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/neue-arzneimittel\/","url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/neue-arzneimittel\/","name":"Neue Arzneimittel - Der Arzneimittelbrief","isPartOf":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/neue-arzneimittel\/#primaryimage"},"image":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/neue-arzneimittel\/#primaryimage"},"thumbnailUrl":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2003\/01\/Abbildung-2003-1-2.gif","datePublished":"2003-01-01T11:00:00+00:00","author":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#\/schema\/person\/a04aadd6db7c06c7464bdbbb5396ed16"},"breadcrumb":{"@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/neue-arzneimittel\/#breadcrumb"},"inLanguage":"de","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/neue-arzneimittel\/"]}]},{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/neue-arzneimittel\/#primaryimage","url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2003\/01\/Abbildung-2003-1-2.gif","contentUrl":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/wp-content\/uploads\/2003\/01\/Abbildung-2003-1-2.gif","width":500,"height":529},{"@type":"BreadcrumbList","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/neue-arzneimittel\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Start","item":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/"},{"@type":"ListItem","position":2,"name":"Neue Arzneimittel"}]},{"@type":"WebSite","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#website","url":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/","name":"Der Arzneimittelbrief","description":"Unabh\u00e4ngige Arzneimittelinformationen","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"de"},{"@type":"Person","@id":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/#\/schema\/person\/a04aadd6db7c06c7464bdbbb5396ed16","name":"Dennis Hoppe","image":{"@type":"ImageObject","inLanguage":"de","@id":"https:\/\/secure.gravatar.com\/avatar\/bfb16656c0e1636d4f543ef457ada76f291324632a293160dd5c869cc3b071d7?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/bfb16656c0e1636d4f543ef457ada76f291324632a293160dd5c869cc3b071d7?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/bfb16656c0e1636d4f543ef457ada76f291324632a293160dd5c869cc3b071d7?s=96&d=mm&r=g","caption":"Dennis Hoppe"}}]}},"_links":{"self":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts\/40454","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/users\/6"}],"replies":[{"embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/comments?post=40454"}],"version-history":[{"count":0,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/posts\/40454\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/media?parent=40454"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/categories?post=40454"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.der-arzneimittelbrief.de\/nachrichten\/api\/wp\/v2\/tags?post=40454"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}